BILL ANALYSIS Ó
SB 1229
Page 1
Date of Hearing: June 21, 2016
ASSEMBLY COMMITTEE ON JUDICIARY
Mark Stone, Chair
SB
1229 (Jackson) - As Amended June 14, 2016
As Proposed to be Amended
SENATE VOTE: 39-0
SUBJECT: HOME-GENERATED PHARMACEUTICAL WASTE: SECURE DRUG
TAKE-BACK BINS
KEY ISSUE: SHOULD A pharmacy or other entity that meets certain
minimum health and safety standards BE GIVEN QUALIFIED IMMUNITY
FROM CIVIL AND CRIMINAL LIABILITY FOR NEGLIGENCE, BUT NOT GROSS
NEGLIGENCE OR WILLFUL OR MALICIOUS MISCONDUCT, IN CONNECTION
WITH any injury or harm that results from the collector
maintaining a secure drug-take back bin on its premises?
SYNOPSIS
Empirical data indicates that the volume of pharmaceutical drugs
prescribed in the U.S. is at a record level and still growing.
More drugs prescribed also means more drugs that expire or, for
various reasons, are never used. Unused prescription drugs then
accumulates in drawers and medicine cabinets across the nation.
SB 1229
Page 2
Until recently, disposal options for unused or leftover drugs,
because of their status as controlled substances, were limited
and largely dictated by law enforcement policy concerns. People
were specifically told that one of their disposal options-easily
the most convenient one-was the undesirable practice of dumping
these medications in the household trash or flushing them down
the toilet, where they end up chemically polluting our
landfills, rivers, and drinking water supply. In addition, a
glut of unused and easily misappropriated medications has helped
feed a growing epidemic of prescription drug abuse, particularly
of narcotic painkillers and opioids, as well-documented in many
recent national press accounts.
This non-controversial bill, sponsored by the California Product
Stewardship Council (CPSC), seeks to encourage pharmacies and
other authorized entities to voluntarily maintain secure drug
take-back receptacles on their premises where their customers
and others can come to safely dispose of unused or expired
medications. To incentivize more of these take-back receptacles
to be introduced into use in California, this bill attempts to
alleviate civil liability concerns that are reportedly an
obstacle to greater voluntary participation in this growing
movement to reduce improper disposal of prescription drugs.
Specifically, the bill provides qualified immunity to entities
that meet certain eligibility conditions and who act responsibly
to comply with specified requirements reflected in recent
federal Drug Enforcement Agency (DEA) regulations, that seek to
ensure public health and safety as well as the proper,
environmentally safe disposal of the unused medications
collected. To qualify for immunity from liability, the
collector must, among many other things, do the following: (1)
comply with all applicable state and federal laws and
regulations relating to the collection of home-generated
pharmaceutical waste for disposal in secure drug take-back bins;
(2) ensure that the secure drug take-back bin is placed in a
location that is regularly monitored by employees of the
registered collector; and (3) ensure that public access to the
secure drug take-back bin is limited to hours in which employees
SB 1229
Page 3
of the registered collector are present and able to monitor its
operation. Proposed amendments to the bill clarify that the
qualified immunity provisions do not apply to gross negligence
or willful or wanton misconduct in either civil or criminal
cases, and that collectors remain liable for any injury or harm
that results from the collector maintaining the secure take-back
bin under the health and safety conditions specified in the
bill, when the injury or harm results from the collector's gross
negligence or willful and wanton misconduct.
This bill enjoys a broad range of support, including the
California Pharmacists Association; environmental groups like
the Sierra Club and Californians Against Waste, who want to
prevent contamination of watersheds and drinking water supplies;
and many local governments, who see the potential for cost
savings since they currently spend millions of dollars managing
the waste stream and regulating intake at county landfills.
This bill was approved in the Senate without receiving a single
"No" vote, and there is no known opposition.
SUMMARY: Provides qualified immunity from civil and criminal
liability of participating entities that take reasonable care to
ensure the health and safety of consumers and employees when
maintaining secure drug take-back bins on their premises.
Specifically, this bill:
1)Defines the term "collector" to include only those entities
authorized by and registered with the federal Drug Enforcement
Administration (DEA) to receive a controlled substance for the
purpose of destruction, if the entity is in good standing with
any applicable licensing authority.
2)Provides that a collector must do all of the following in
order to receive qualified civil or criminal immunity from
liability:
SB 1229
Page 4
a) Comply with all applicable state and federal laws and
regulations relating to the collection of home-generated
pharmaceutical waste for disposal in secure drug take-back
bins, including, but not limited to, the federal Secure and
Responsible Drug Disposal Act of 2010.
b) Notify local law enforcement and any local environmental
health department as to the existence and location of any
secure drug take-back bin on the collector's premises and
the status of the collector's registration as a collector
with the DEA.
c) Ensure that the secure drug take-back bin is placed in a
location that is regularly monitored by employees of the
registered collector.
d) Ensure that conspicuous signage is posted on the secure
drug take-back bin that clearly notifies customers as to
what controlled and non-controlled substances are and are
not acceptable for deposit into the bin, as well as the
hours during which collection is allowed.
e) Ensure that public access to the secure drug take-back
bin is limited to hours wherein employees of the registered
collector are present and able to monitor the operation of
the secure drug take-back bin.
f) Regularly inspect the area surrounding the secure drug
take-back bin for potential tampering or diversion, and
maintain certain records and logs for at least two years,
in writing or electronic form, that may be used to
demonstrate regular inspection of the area.
SB 1229
Page 5
g) Notify local law enforcement authorities of any
suspected or known tampering, theft, or significant loss of
controlled substances within one business day of discovery.
h) Notify local law enforcement as to any decision to
discontinue its voluntary collection of controlled
substances, as specified.
3)Provides that a collector that maintains a secure drug
take-back bin, in good faith and not for compensation, shall
not be liable in a civil action, or be subject to criminal
prosecution, for maintaining a secure drug take-back bin on
its premises if the collector takes all of the steps specified
in # 2), above.
4)Clarifies that the terms and conditions specified in # 2)
shall be construed in a manner consistent with the
requirements imposed by the DEA's final rule governing the
secure disposal of controlled substances pursuant to 79 Fed.
Reg. 53519-70 and any regulations promulgated by the state of
California.
5)Clarifies that a collector remains liable for any injury or
harm that results from the collector maintaining the secure
take-back bin under the health and safety conditions specified
in the bill, unless the injury or harm results from the
collector's gross negligence or willful and wanton misconduct.
6)Clarifies that the immunity in # 3) would not apply in a case
of personal injury or wrongful death which results from the
collector's gross negligence or willful or wanton misconduct
in maintaining a secure drug take-back bin.
SB 1229
Page 6
7)Provides that nothing in this bill shall be construed to
require entities that may qualify as a collector to acquire,
maintain, or make available to the public a secure drug
take-back bin on its premises.
EXISTING LAW:
1)Pursuant to the Medical Waste Management Act, requires the
Department of Public Health to regulate the management and
handling of medical waste, including pharmaceutical waste, as
defined. (Part 14 of Division 104 of the Health and Safety
Code, commencing with Section 117600.)
2)Defines "pharmaceutical waste" as any pharmaceutical that for
any reason may no longer be sold or dispensed for use as a
drug and excludes from this definition those pharmaceuticals
that still have potential value to the generator because they
are being returned to a reverse distributor for possible
manufacturer credit.
3)Specifies that waste comprised only of pharmaceuticals is
hazardous, and is considered "medical waste," although it is
not subject to hazardous waste laws, as specified.
4)Provides that no person who in good faith, and not for
compensation, renders emergency medical or nonmedical care at
the scene of an emergency shall be liable for any civil
damages resulting from any act or omission other than an act
or omission constituting gross negligence or willful or wanton
misconduct. (Health and Safety Code Section 1799.102.)
SB 1229
Page 7
5)Provides that everyone is responsible, not only for the result
of his or her willful acts, but also for an injury occasioned
to another by his or her want of ordinary care or skill in the
management of his or her property or person, except so far as
the latter has, willfully or by want of ordinary care, brought
the injury upon himself or herself. (Civil Code Section 1714
(a).)
6)Provides that a person or entity that acquires an automatic
external defibrillator (AED) for emergency use is not liable
for any civil damages resulting from any acts or omissions
when the AED is used to render emergency care, provided that
the person or entity has complied with certain notice,
maintenance, and other reasonable care requirements under the
Health and Safety Code, as specified; except that these
qualified immunities do not apply in the case of personal
injury or wrongful death which results from the gross
negligence or willful or wanton misconduct of the person who
uses the AED to render emergency care. (Civil Code Section
1714.21, subd. (d) and (e).)
7)Provides that any prehospital emergency medical care person or
lay rescuer, as specified, who administers an epinephrine
auto-injector, in good faith and not for compensation, to
another person who appears to be experiencing anaphylaxis at
the scene of an emergency situation is not liable for any
civil damages resulting from his or her acts or omissions in
administering the epinephrine auto-injector, if that person
has complied with specified requirements of the Health and
Safety Code. Further provides that this protection does not
apply in a case of personal injury or wrongful death that
results from the gross negligence or willful or wanton
misconduct of the person who renders emergency care treatment
by the use of an epinephrine auto-injector. (Civil Code
Section 1714.23, subd. (b) and (c).)
SB 1229
Page 8
FISCAL EFFECT: As currently on print this bill is keyed
non-fiscal.
COMMENTS: This bill, sponsored by the California Product
Stewardship Council (CPSC), seeks to encourage pharmacies and
other authorized entities to voluntarily maintain secure drug
take-back receptacles on their premises where their customers
and others can come to safely dispose of unused or expired
medications. To incentivize more of these take-back receptacles
to be introduced in California, this bill attempts to alleviate
the civil liability concerns that are reportedly an obstacle to
greater voluntary participation in this growing movement to
reduce improper disposal of prescription drugs. Specifically,
the bill provides qualified immunity to entities that meet
certain eligibility conditions and that act to comply with
specified requirements, reflected in recent federal DEA
regulations, that seek to ensure public health and safety as
well as the proper disposal of the pharmaceutical waste
collected.
In explaining the compelling need for this bill, the author
states:
Home-generated pharmaceutical waste (i.e., prescription
or over-the-counter human or veterinary drugs that are
"left over" from treatment or have expired), has become
an increasing problem nationwide and in California.
With the rise of prescription drug abuse, these excess
drugs-often stored in medicine cabinets or under sinks
for years-have found their way into recreational use by
teens or are otherwise misused by seniors or others.
People taking un-prescribed or expired drugs are
creating a growing public health and safety risk.
Without a safe means of disposal, many people with
excess drugs are turning to throwing them in the trash
SB 1229
Page 9
or flushing them in a toilet. This creates serious
problems with soil and water quality, especially since
our water treatment plants are not capable of removing
pharmaceuticals from wastewater.
Law enforcement and pioneering pharmacies concerned
with public safety and environmental health have been
hosting drug take-back programs and bins voluntarily.
These early efforts are laudable, but the scope of
these drug take-back options has remained relatively
small in relation to the demand for convenient and safe
disposal. Many pharmacies have raised concerns
regarding potential liability as the reason behind
their reluctance to host a drug take-back bin.
In order to help protect the public from prescription
drug abuse and to protect water quality from
home-generated pharmaceutical waste, SB 1229 would
encourage pharmacies to host secure drug take-back bins
by (1) establishing a duty of care for the proper
oversight of secure drug take-back bins; and (2)
providing limited civil and criminal liability immunity
for pharmacies hosting drug take-back bins if they meet
that duty of care.
High volume of unused pharmaceuticals and the social and
environmental problems associated with improper disposal. The
SB 1229
Page 10
volume of pharmaceutical drugs that are prescribed in the U.S.
is estimated to be at unprecedented levels, and is projected to
continue growing even further in coming years. According to
predicted figures by the U.S. Centers for Medicare & Medicaid
Services (CMS), which publishes the National Health Expenditure
(NHE) Projections, approximately $305.1 billion of prescription
drugs were predicted to be prescribed in the U.S. in 2014, with
that total increasing to $328.4 billion in 2015, and $343.2
billion in 2016. (NHE Projections 2014-2024, available at
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statisti
cs-Trends-and-Reports/NationalHealthExpendData/
NationalHealthAccounts Projected.html.) The proportion of
prescribed drugs that are not consumed by the patient, and thus
potentially disposable, has been the subject of many studies in
the U.S. and in Europe, but is difficult to precisely estimate
because of differing methodologies. In 2009, researchers in
Washington reviewed many of these studies and found that perhaps
between 10% and 33% of prescribed drugs go unused. In one study
conducted in Northern California and cited by these researchers,
examination of containers containing unused medicine revealed an
average of 52% of the original medicine still inside, unused.
(Grasso, Cheri, et al., (2009) Secure Medicine Return in
Washington State, The PH:ARM Pilot. See:
http://www.takebackyourmeds.org/pdf-files/ pharm-final-report.)
These figures don't even include over-the-counter medications,
which pose similar problems of pollution and drug abuse if
unused and not properly disposed.
According to the sponsor, unused drugs that accumulate in homes
increase the risk of preventable poisonings, drug abuse, and
overdoses. Recent data show that drug overdoses are now the
leading cause of injury death in the United States, even
surpassing motor vehicle crash deaths. According to the Centers
for Disease Control and Prevention (CDC), nearly half a million
people died from drug overdoses from 2000 to 2014, and the
SB 1229
Page 11
majority of drug overdose deaths involve an opioid, including
prescription pain relievers and heroin. Overdose is a growing
problem even among school-age youth. The 2014 National Survey
on Drug Use and Health reported an estimated 0.7 percent of
adolescents aged 12 to 17 (approximately 168,000 adolescents)
had a pain reliever use disorder in 2014, while 18,000
adolescents, representing 0.1 percent of those in the same age
group, had a heroin use disorder in 2014. (Available at:
https://nsduhweb.rti.org/respweb/homepage.cfm .)
Apparently lacking knowledge of better disposal options, many
people simply throw their unused medications into the household
trash, or flush them down the toilet. Flushing medication into
sewage systems, however, harms the environment, including
wildlife, and contaminates drinking water sources, such as
aquifers and rivers. According to a 2002 study by the U.S.
Geological Survey, researchers sampling 139 streams across 30
states found that 80 percent had measurable concentrations of
prescription and nonprescription drugs, steroids, and
reproductive hormones. ("Water-Quality Data for
Pharmaceuticals, Hormones, and Other Organic Wastewater
Contaminants in U.S. Streams, 1999-2000" (2002) USGS; available
at: http://toxics.usgs.gov/pubs/OFR-02-94/index.html .) Exposure,
even to low levels of pharmaceuticals, has been shown to have
negative effects on fish and other aquatic species and may have
negative effects on human health. A 2010 Associated Press
investigation found medications in watersheds near Los Angeles,
Riverside and Long Beach, raising strong public health concerns
about bacterial resistance to antibiotics and endocrine
disruption in aquatic organisms. ("AP investigation details
pharmaceuticals found in watersheds of 28 major metro areas."
(2010) Associated Press; available at: http://hosted.ap.org/
specials/interactives/pharmawater_site/day1_07.html.)
SB 1229
Page 12
Federal actions to encourage drug collection programs and reduce
improper disposal of unused drugs. In 2010, Congress enacted
the Secure and Responsible Drug Disposal Act of 2010 (Public Law
111-273; hereafter "Disposal Act.") Before the Disposal Act,
individuals who wanted to dispose of unused, unwanted, or
expired pharmaceutical controlled substances had limited options
because the federal Controlled Substances Act (21 U.S.C. Sec.
801 et seq.; hereafter "CSA") only permitted individuals were
allowed to destroy those substances (e.g., by flushing or
discarding), surrender them to law enforcement, or seek
assistance from the federal Drug Enforcement Agency
Administration (DEA). These restrictions resulted in the
accumulation of pharmaceutical controlled substances in
household medicine cabinets that were available for abuse,
misuse, diversion, and accidental ingestion. The Disposal Act
amended the CSA to authorize specified individuals, referred to
as "ultimate users," to deliver their pharmaceutical controlled
substances to another person for the purpose of disposal in
accordance with regulations promulgated by the United States
Attorney General.
On September 9, 2014, the DEA issued its final rule (79 Fed.
Reg. 53519-70) governing the secure disposal of controlled
substances by ultimate users. Those regulations implement the
Disposal Act by expanding the options available to collect
controlled substances from ultimate users for the purpose of
disposal, including take-back events, mail-back programs, and
collection receptacle locations. Those regulations, among other
things, allow authorized manufacturers, distributors, reverse
distributors, narcotic treatment programs, hospitals/clinics
with an on-site pharmacy, and retail pharmacies to voluntarily
administer mail-back programs and maintain collection
SB 1229
Page 13
receptacles.
According to CPSC, medication collection programs are
recommended by the White House Office of National Drug Control
Policy (ONDCP), Drug Enforcement Administration (DEA), Food and
Drug Administration (FDA), and the Environmental Protection
Administration (EPA) as a more secure and environmentally safe
method of disposal than throwing medicines in the trash.
("Report on Options for Managing Home Generated Medications in
San Joaquin County" (2016) California Product Stewardship
Council.) Since passage of the Disposal Act, the DEA has
coordinated National Prescription Drug Take-Back Day events at
sites across the country to collect unused drugs and educate the
public about responsible means of disposal and the potential for
abuse of these medications. Furthermore, the ONDCP's 2015
National Drug Control Strategy calls for increased use of
prescription medication return/take-back programs as one of four
pillars in combating prescription medication misuse, along with
the education of health care providers, patients, and families;
enhancing and encouraging the establishment of prescription drug
monitoring programs statewide; and increased enforcement to
address doctor shopping and pill mills.
By offering qualified immunity from liability for maintaining a
secure collection bin, this bill seeks to encourage more
pharmacies and other authorized entities to voluntarily
participate in secure drug-take back programs. Generally
speaking, current law holds every person responsible, not only
for the result of his or her willful acts, but also for an
injury occasioned to another by his or her want of ordinary care
or skill in the management of his or her property or person,
except so far as the latter has, willfully or by want of
ordinary care, brought the injury upon himself. (Civil Code
Section 1714 (a).) However, the Legislature has authorized
SB 1229
Page 14
qualified immunity from civil liability in order to promote good
public policy and actions that benefit the public generally. The
public policy goal of qualified immunity is to encourage a
person or entity to undertake an activity or responsibility that
the person or entity would otherwise not be compensated,
required or willing to do (as a duty of employment or a
professional standard of conduct, for example) because the act
would be beneficial to the public interest. For instance, in
order to encourage persons to render potentially lifesaving care
in medical emergencies, California law provides qualified
immunities to lay persons who use an automated external
defibrillator (AED) device in emergency situations (Civil Code
Section 1714.21) and to those laypersons who administer opioid
antagonist medication to persons experiencing an opioid overdose
(Civil Code Section 1714.23).
As previously discussed, this bill is intended to further the
laudable public policy of reducing prescription drug abuse and
protecting water quality from home-generated pharmaceutical
waste by encouraging pharmacies to voluntarily set up and
maintain a drug take-back receptacle for their patients,
something they are otherwise not required to do. According to
the author, to further these policy goals it is necessary to
establish new qualified immunities because the threat of civil
liability (whether real or imagined) discourages pharmacies and
other entities from voluntarily maintaining secure drug
take-back receptacles. According to the California Pharmacists
Association:
[O]ne barrier discouraging independent pharmacies from
hosting collection receptacles continues to be the fear
of the civil liability associated with doing so. A
pharmacy that tries to help patients by hosting a
collection receptacle and takes all the right steps to
ensure the safe and secure operation of that receptacle
should be confident that they will not be held civilly
liable for events outside of their control.
SB 1229
Page 15
In order to incentivize more pharmacies to voluntarily set up
and maintain a drug take-back receptacle for their patients,
this bill would provide pharmacies and other authorized entities
with qualified liability protections, as specified, as long as
they comply with certain requirements for maintaining a secure
drug take-back receptacle.
Characteristics of the qualified immunity provisions and their
relationship to federal rules. The qualified immunity
provisions of this bill are limited with respect to who they
apply to and the conditions under which immunity becomes
available-in both cases respecting the need to observe federal
regulations governing the collection of controlled substances.
First, the immunity provisions only extend to pharmacies and
entities that qualify as authorized "collectors" under federal
DEA regulations. As defined by this bill, a collector must be
an entity authorized by and registered with the DEA to receive a
controlled substance for the purpose of destruction. Under
federal regulations, this can include registered manufacturers,
distributors, reverse distributors, narcotic treatment programs,
hospital or clinics with an on-site pharmacy, or retail
pharmacies that are so authorized and registered with the DEA.
In addition, because an entity would also have to be licensed in
California under state law whether or not it voluntarily
maintains a drug take-back bin, this bill also requires that a
collector be in good standing with any applicable state
licensing authority in order to qualify for these immunity
protections.
Second, the bill's qualified immunity provisions only protect
the collector from liability if the collector, not for
compensation and acting in good faith, complies with a number of
SB 1229
Page 16
specified requirements that operate to ensure the health and
safety of consumers and employees and the proper disposal of the
home-generated pharmaceutical waste contained in the secure drug
take-back bin. To qualify for immunity from liability, the
collector must, among other things: (1) comply with all
applicable state and federal laws and regulations relating to
the collection of home-generated pharmaceutical waste for
disposal in secure drug take-back bins; (2) ensure that the
secure drug take-back bin is placed in a location that is
regularly monitored by employees of the registered collector;
(3) ensure that public access to the secure drug take-back bin
is limited to hours in which employees of the registered
collector are present and able to monitor the operation of the
secure drug take-back bin; and (4) ensure that conspicuous
signage is posted on the secure drug take-back bin that clearly
notifies customers as to what controlled and noncontrolled
substances are and are not acceptable for deposit into the bin,
as well as the hours during which collection is allowed.
In addition to the above conditions, there are several
notification requirements that must also be followed in order to
obtain immunity. The collector must: (1) notify local law
enforcement and any local environmental health department as to
the existence and location of any secure drug take-back bin on
the collector's premises and the status of the collector's
registration as a collector with the federal DEA; (2) notify
local law enforcement of any suspected or known tampering,
theft, or significant loss of controlled substances, within one
business day of discovery, or, if the collector maintains daily
business hours, within one calendar day; and (3) notify local
law enforcement as to any decision to discontinue its voluntary
collection of controlled substances and provide documentation of
its written notification to the federal DEA's Registration Unit
as otherwise required under federal laws and regulations.
SB 1229
Page 17
According to the author, the intent of the bill is to ensure
that individuals are not provided immunity from either civil or
criminal liability for injuries or harm resulting from gross
negligence or willful or wanton misconduct-and this application
of the rule is not limited just to civil cases of personal
injury or wrongful death in the civil context, as may arguably
be implied by the current language of proposed Section 1712.24,
subdivision (c). Therefore, the author proposes the following
amendments to clarify the qualified immunity provisions do not
apply to gross negligence or willful or wanton misconduct in
either civil or criminal cases:
On page 4, lines 13 to 20, make the following changes:
(b) Any collector that maintains a secure drug take-back bin
shall not be liable in a civil action, or be subject to
criminal prosecution, for any injury or harm that results from
the collector maintaining a secure drug take-back bin on its
premises if provided that the collector, not for compensation,
acts in good faith to take all of the following steps to
ensure the health and safety of consumers and employees and
the proper disposal in the waste stream of the home-generated
pharmaceutical waste contained in a secure drug take-back bin ,
unless the injury or harm results from the collector's gross
negligence or willful and wanton misconduct :
[. . . ]
On page 5, delete lines 24 to 27, and on line 28, replace "(d)"
with "(c)"
SB 1229
Page 18
Special requirement for collectors to maintain logs of
inspections. As noted above, the bill requires that a collector
regularly inspect the area surrounding the secure drug take-back
receptacle for potential tampering or diversion-a safety
requirement that is also reflected in the DEA 2014 regulations.
Specific to this bill, according to the author, is a further
requirement that record logs of those inspections, reflecting
the date and time of the inspection, be maintained and retained
by the take-back program for two years. The bill also requires
retention of other records or reports mandated by federal or
state regulations for a minimum of two years, unless regulations
mandate a longer period. Recent amendments to the bill clarify
that these logs shall be maintained in writing or electronic
form, may be combined with logs required by state or federal
regulations, and may be used to demonstrate regular inspection
of the area surrounding the take-back receptacle. This last
requirement may be particularly useful to a collector seeking to
claim immunity in court pursuant to these provisions, because
the logs could help the collector prove it has complied with the
minimum requirements necessary to establish the qualified
immunity protections.
Previous Related Legislation. SB 738 (Huff), Ch. 132, Stats.
2015, provides that an authorizing physician and surgeon shall
not be subject to professional review, be liable in a civil
action, or be subject to criminal prosecution for the issuance
of a prescription or order to a qualified supervisor of health
or administrator at a school district, county office of
education, or charter school for epi-pens pursuant to specified
law, unless the physician and surgeon's issuance constitutes
gross negligence or willful or malicious conduct.
AB 635 (Ammiano), Ch. 707, Stats. 2013, provides that a licensed
SB 1229
Page 19
health care provider who acts with reasonable care and issues a
prescription for, or an order for the administration of, an
opioid antagonist to a person experiencing or suspected of
experiencing an opioid overdose is not subject to professional
review, liable in a civil action, or subject to criminal
prosecution for issuing the prescription or order. The bill also
provide, that a person who is not otherwise licensed to
administer an opioid antagonist, but who meets other specified
conditions, is not subject to professional review, liable in a
civil action, or subject to criminal prosecution for
administering an opioid antagonist.
REGISTERED SUPPORT / OPPOSITION:
Support
California Product Stewardship Council (sponsor)
American Federation of State, County, and Municipal Employees
(AFSCME)
Applied Pharmacy Solutions
Area Agency on Aging
Californians Against Waste
California Alliance for Retired Americans
SB 1229
Page 20
California Association of Sanitation Agencies
California Pharmacists Association
California Special Districts Association
California State Association of Counties
California State PTA
City of Palo Alto
City of Torrance
Clean Water Action
County Health Executives Association of California
County of Los Angeles
County of Santa Barbara
County of Riverside
County Sanitation Districts of Los Angeles County
SB 1229
Page 21
David Cortese, Santa Clara County Supervisor
League of California Cities
Los Angeles County Solid Waste Management Cmte./ Integrated
Waste Management Task Force
Medication Education and Disposal Safety Coalition
Napa Sanitation District
Nate Miley, Alameda County Supervisor
Sacramento State Student Health and Counseling Services Pharmacy
San Luis Obispo County Integrated Waste Management Authority
Santa Clara County Board of Supervisors
Sierra Club California
Solid Waste Association of North America
South Bay Cities Council of Governments
SB 1229
Page 22
StopWaste
Summerland Sanitary District
Research in Social and Administrative Pharmacy
Opposition
None on file
Analysis Prepared by:Anthony Lew / JUD. / (916)
319-2334